Abstract
Background
Increasing evidence supports lung cancer screening with low-dose CT (LDCT) imaging. However, the benefits of LDCT screening for lung cancer may not be immediate, making it unlikely to benefit patients with limited life expectancy.
Research Question
What is the time to benefit (TTB) from LDCT screening for individuals at high risk for lung cancer?
Increasing evidence supports lung cancer screening with low-dose CT (LDCT) imaging. However, the benefits of LDCT screening for lung cancer may not be immediate, making it unlikely to benefit patients with limited life expectancy.
Research Question
What is the time to benefit (TTB) from LDCT screening for individuals at high risk for lung cancer?
| Original language | English |
|---|---|
| Pages (from-to) | 1049-1056 |
| Number of pages | 8 |
| Journal | Chest |
| Volume | 168 |
| Issue number | 4 |
| Early online date | 18 Jun 2025 |
| DOIs | |
| Publication status | E-pub ahead of print - 18 Jun 2025 |
Keywords
- clinical benefit
- low-dose CT
- lung cancer
- screening